Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Juggernaut Files for Approval of Private Placement Financing June 13, 2025 Empire Metals Limited Announces Warrant Exercise June 13, 2025 HyProMag USA Receives “Make More in America” Domestic Finance Letter of Interest for up to US$92 Million From US EXIM Bank June 13, 2025
HyProMag USA Receives “Make More in America” Domestic Finance Letter of Interest for up to US$92 Million From US EXIM Bank June 13, 2025